Chen, Tai-Tsang <br/><br/>
Predicting analysis times in randomized clinical trials with cancer immunotherapy.  [electronic resource] 

 -  BMC medical research methodology  Feb 2016 
 - 12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2288 
<br/><br/><label>Standard No.: </label>10.1186/s12874-016-0117-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Antibodies, Monoclonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Clinical Trials, Phase III as Topic--methods<br/>Dacarbazine--administration & dosage<br/>Humans<br/>Immunotherapy--methods<br/>Ipilimumab<br/>Kaplan-Meier Estimate<br/>Melanoma--drug therapy<br/>Models, Theoretical<br/>Neoplasms--immunology<br/>Outcome Assessment, Health Care--methods<br/>Prognosis<br/>Randomized Controlled Trials as Topic--methods<br/>Reproducibility of Results<br/>Research Design<br/>Retrospective Studies<br/>Time Factors